Carl-Zeiss AG - Middle East and Africa Ophthalmic drugs Market.
Middle East And Africa Ophthalmic Drugs Market By Disease Indication, By Dosage Form, By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)
(EMAILWIRE.COM, November 21, 2018 ) Recent Developments:
After reorganizing its ophthalmic business in 2016 by combining the preceding two strategic business units, ophthalmic systems and surgical ophthalmology, into one unit that encompasses the entire ophthalmic portfolio with the goal to optimize sales, boost market breach and grow globally, the Carl Zeiss Meditec Group amplified revenues for the fiscal year ended Sep. 30 in 2016 by nearly 5% to €1.1bn compared to the prior year. In Fiscal Year 2018 ophthalmic devices posted combined total revenues of €843.9m compared to €790.2m in the prior fiscal year, driven mostly by refractive laser systems.
In the refractive laser surgery market, parent company, Carl Zeiss Meditec AG benefitted from the FDA approval and launch of the minimally invasive SMILE procedure, in the US last September, which uses the VisuMax femtosecond laser for correcting myopia.
The company hopes to rise through innovation and plans to invest 10-11% in R&D annually.
View sample here:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-ophthalmic-drugs-market-5495/request-sample
Market Trends:
Market Data Forecast has released a report on Middle East and Africa open Ophthalmic drugs Market; Retinal disorders captured largest market share however glaucoma is anticipated to grow with the highest CAGR in the forecast period due to Increasing number of people suffering from retinal disorders all over the world, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market..
The Middle East and Africa Ophthalmic Drugs market size was around USD 2.66 billion in 2018. It is expected to grow at a CAGR of 1.8% to reach USD 2.91 billion by 2023. It captures 8% of the global market.
Other Key players in the market are Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.
For the detailed information please follow the link:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-ophthalmic-drugs-market-5495/
Scope of the Report:
The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.
The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.
What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
After reorganizing its ophthalmic business in 2016 by combining the preceding two strategic business units, ophthalmic systems and surgical ophthalmology, into one unit that encompasses the entire ophthalmic portfolio with the goal to optimize sales, boost market breach and grow globally, the Carl Zeiss Meditec Group amplified revenues for the fiscal year ended Sep. 30 in 2016 by nearly 5% to €1.1bn compared to the prior year. In Fiscal Year 2018 ophthalmic devices posted combined total revenues of €843.9m compared to €790.2m in the prior fiscal year, driven mostly by refractive laser systems.
In the refractive laser surgery market, parent company, Carl Zeiss Meditec AG benefitted from the FDA approval and launch of the minimally invasive SMILE procedure, in the US last September, which uses the VisuMax femtosecond laser for correcting myopia.
The company hopes to rise through innovation and plans to invest 10-11% in R&D annually.
View sample here:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-ophthalmic-drugs-market-5495/request-sample
Market Trends:
Market Data Forecast has released a report on Middle East and Africa open Ophthalmic drugs Market; Retinal disorders captured largest market share however glaucoma is anticipated to grow with the highest CAGR in the forecast period due to Increasing number of people suffering from retinal disorders all over the world, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market..
The Middle East and Africa Ophthalmic Drugs market size was around USD 2.66 billion in 2018. It is expected to grow at a CAGR of 1.8% to reach USD 2.91 billion by 2023. It captures 8% of the global market.
Other Key players in the market are Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.
For the detailed information please follow the link:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-ophthalmic-drugs-market-5495/
Scope of the Report:
The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.
The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.
What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results